Find premium construction reports

DocStore » Research Reports » Construction Reports

Per Page: 15 25 50

«1...

Opmedic Group Inc. (OMG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

OPMEDIC Group Inc. (OPMEDIC Group) is a healthcare services provider, based in Canada. The company provides fertility and human genetic services, sperm banking services, surgical and endoscopic services and facilities to the patients and surgeons. It provides its services through three divisions, namely, Procrea clinics division, Procrea cryopreservation center and the Opmedic division. The services provided by Procrea clinics include fertility clinics, diagnostic laboratories, pre-natal screening and foetal ultrasounds. The Procrea clinics helps individuals conceive children by using biotechnology to assist in the diagnosis, treatment and prevention of diseases related to reproductive medicine. OPMEDIC Group is headquartered in Roat Mount Royal, Quebec, Canada.
Orbus Pharma Inc. (ORB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Orbus Pharma Inc. (Orbus Pharma), formerly known as BOVAR Inc, is a publicly held pharmaceutical company. It is engaged in the development and manufacture of generic oral dose products. The company is specialized in developing oxcarbazepine to treat various types of seizures in the treatment of epilepsy, amitriptyline to treat symptoms of depression and metoprolol succinate XR to treat high blood pressure, prevent angina (chest pain), and in combination with other medications to treat heart failure. It also develops cefuroxime axetil to treat certain infections caused by bacteria, such as bronchitis, lyme disease and gonorrhoea, as well as infections of the throat, ears, sinus, skin, and urinarytract; and fluvastatin for the production of cholesterol in the body, for preventing heart disease, angina, strokes, and heart attacks. In addition, Orbus Pharma is engaged in offering pharmaceutical manufacturing and drug development services for third party products. It has spanned its business operations throughout the regions of the Europe, Canada, Central America, and Asia. The company is headquartered at Markham, Canada.
Ophthotech Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Ophthotech Corp. (Ophthotech) is a clinical stage biopharmaceutical company based in the US. The company develops and commercializes therapies for dry and wet age-related macular degeneration (AMD) in an accelerated manner. It has developed three new molecular entities targeting the key molecular event contributing to the pathology of age-related macular degeneration which include e10030, arc1905 and volociximab. e10030 is an anti-platelet-derived growth factor. arc1905 is a pegylated aptamer targeting the C5 component of the complement cascade. volociximab is a monoclonal antibody targeting the transmembrane receptor. Ophthotech is headquartered in Princeton, New Jersey, the US.
Oncothyreon Inc. (ONTY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Oncothyreon Inc. (Oncothyreon) is a pharmaceutical and health care service provider, based in the US. The company develops therapeutic products for the cancer treatment. Its lead product candidate stimuvax is a therapeutic vaccine designed to stimulate an individual's immune system to recognize cancer cells and control the growth and spread of cancers in order to increase the survival of cancer patients that is currently in phase III development for non-small cell lung cancer (NSCLC), ONT-10 is a therapeutic vaccine designed to direct an individual's immune system to identify and destroy cancer cells. The company entered into an exclusive, worldwide license with Merck KGaA of Darmstadt, Germany (Merck KgaA) to develop, manufacture and commercialize stimuvax. Oncothyreon is headquartered in Seattle, Washington, the US.
PATH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

PATH is a health solutions provider, based in the US. The company develops and delivers the high-impact, low-cost solutions, from lifesaving vaccines and devices to collaborative programs with communities. It provides solutions for emerging and epidemic diseases, like AIDS, tuberculosis, and malaria. The company operates as an international non-profit organization which is focused in the distribution of condoms, birth control pills, intrauterine devices, among other modern forms of pregnancy prevention. PATH works in collaboration with diverse public and private-sector partners to provide appropriate health technologies and vital strategies. It has a wide network across the globe with its offices located in Africa, Asia, Eastern Europe, Latin America, North America and Europe. PATH is headquartered in Seattle, Washington, the US.
Amalyte Pharmaceuticals, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Amalyte Pharmaceuticals, LLC (Amalyte) is a pharmaceutical and healthcare service provider, based in the US. The company develops novel therapies for treatment of immune and inflammatory diseases. Its lead product AM3301 is an in-licensed molecule anti-inflammatory new chemical entity for multiple clinical indications in gastrointestinal, inflammatory, and rhinitis and asthma diseases. Amalyte offers topical PDE4 Inhibitors, a topical anti-inflammatory PDE4 inhibitor for atopic dermatitis and psoriasis; and Gal T-2 Modulators, Gal T-2 inhibitors for restenosis, polycystic kidney diseases, and age-related macular degeneration. The company operates as a subsidiary of Kemin Industries Inc. Amalyte is headquartered in Des Moines, Iowa, the US.
Clinquest Group, B.V. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Clinquest Group, B.V. (Clinquest) is a contract research organization, based in Netherlands. The company is involved in consulting services for drug discovery and development, implementation, post-approval expertise and compound partnering programs, serving the pharmaceutical, biotechnology, biomedical device and medical data industries. The company's drug development team enables its clients to bring their products into the Clinical Trial quickly. It also helps them in all aspects from the preclinical phase of development to the support of product manufacturing. Moreover, the company divides its business into three segments, namely, pharmaceutical development, clinical trial implementation, and pharmacovigilance and medical information. In addition, the company provides its services to the pharmaceutical, biotechnology, biomedical device and medical data industries. Clinquest is headquartered in Amsterdam, Netherlands.
Diffusion Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Diffusion Pharmaceuticals LLC (Diffusion) is a clinical-stage drug-development company based in the US. The company develops first-in-class drugs which target the numerous unmet medical needs characterized by hypoxia at the cellular level. It provides treatment for life-threatening medical conditions by increasing the amount of oxygen to hypoxic tissues. The product of Diffusion, Tran’s sodium crocetinate (TSC) is a synthetic small-molecule, which uses a novel method of action to improve oxygen diffusion to oxygen-deprived tissue. TSC is used in the areas such as, cardiovascular and respiratory diseases, cancer, stroke and other serious diseases. The company is collaborated with research organizations which include The Johns Hopkins University, University of Virginia (UVA), and Uniformed Services University of the Health Sciences (UHSU) and government organizations such as the National Cancer Institute’s (NCI) Adult Brain Tumor Consortium (ABTC) and the Office of Naval Research (ONR). The company is headquartered in Charlottesville, Virginia, the US.
Alvine Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Alvine Pharmaceuticals, Inc. (Alvine) is a clinical stage biopharmaceutical company. It focuses on the development of therapeutics for celiac disease and other autoimmune/inflammatory diseases. The company's product pipeline includes ALV003 for the treatment of celiac disease. ALV003 is a mixture of two proteases, namely, ALV001 and ALV002. ALV001 and ALV002 are the modified recombinant versions of a Hordeum vulgare (barley) cysteine endoprotease B, isoform 2 (EP-B2) proenzyme; and Sphingomonas capsulata prolyl endopeptidase (SC-PEP) respectively. The company is backed up by a number of investors that include Abbott Biotech Ventures, Black-River Asset Management, Flagship Ventures, InterWest Partners, Panorama Capital, Prospect Venture Partners, and Sofinnova Ventures. Alvine is headquartered in San Carlos, California, the US.
Promedior, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Promedior, Inc. (Promedior) is a biotechnology company, based in the US. The company develops novel therapeutics for the treatment of fibrotic disorders and diseases. Its pipeline of drug candidates includes PRM-151, PRM-167, inhaled, subcutaneous, and rhPTX-2 fusions. The company conducts research in detecting and developing novel drugs for the treatment and prevention of fibrotic pathology. It provides PRM-151, a recombinant form of human pentraxin-2 protein formulated for intravenous or local injection. Promedior has collaboration and extramural research program apart from its drug discovery programs. The company was incorporated in 2006. Promedior is headquartered in Malvern, Pennsylvania, the US.
Trevena, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Trevena, Inc. (Trevena) is a clinical stage pharmaceutical company. It carries out the discovery and development of the next generation of G-protein coupled receptor (GPCR) targeted medicines. The GPCR are associated with beneficial versus adverse biological effects. The company discovered novel drug candidates for the treatment of acute heart failure and pain as well as other compounds for treating multiple CNS conditions. Its advanced compound, TRV027, is a ß-arrestin biased ligand of the angiotensin receptor (AT1R) which is in in mid-stage clinical trials for the treatment of acute heart failure. The company’s TRV130 compound is a G protein-biased µ-opioid receptor ligand which is in preclinical studies for the treatment of acute post-operative pain. Trevena is headquartered in King of Prussia, Pennsylvania, the US.
Cyclogenix Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Cyclogenix Ltd (Cyclogenix) is an early stage biotechnology company based in the UK. The company develops and commercializes a novel micro-protein display scaffold which is derived from naturally-occurring cyclic peptides termed cyclotides. It develops the technology that delivers the next wave of protein-derived therapeutic compounds based on a variety of cyclotides. Cyclogenix is collaborated research agreement with Wyeth Pharmaceuticals to investigate the properties of the scaffold. The company uses Cyclogenix’s novel drug discovery technology platform in producing therapeutic peptides. It also provides the library facilities for the development of novel therapeutic peptide products. Cyclogenix is headquartered in Bucksburn, Aberdeen, the UK.
Agios Pharmaceuticals - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Agios Pharmaceuticals (Agios) is a biopharmaceutical company, based in the US. The company discovers and develops therapeutics in the field of cancer metabolism. It develops drugs focusing on glycolysis, fatty acid metabolism and autophagy. Agios drugs are used in the areas of autoimmune, inflammatory and neurological diseases. The company conducts its research and development activities for the development of novel anti cancer therapeutics. It has entered into a global strategic collaboration with Celgene, a leading biotechnology company. The company was formerly known as Cancer Metabolism Therapeutics, Inc. Agios is headquartered in Cambridge, Massachusetts, the US.
Hawthorn Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Hawthorn Pharmaceuticals, Inc. (Hawthorn) is a pharmaceutical and health care service provider, based in the US. The company develops, sells and markets prescription products. It provides products in the areas of dermatology, iron deficiency, nephrology, oncology, oral steroids, pain management, respiratory, urology. The company has relationships with purchases of pharmaceuticals in the US including many major chains and wholesalers for the commercialization of its products. It offers ELIPHOS for the control of hyperphosphatemia in end stage renal failure and does not promote aluminum absorption. The company and The University of Pittsburgh has signed an exclusive global licensing agreement of CSPG4 a specific novel monoclonal antibodies for cancer. Hawthorn is headquartered in Madison, Mississippi, the US.
AlloCure Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

AlloCure Inc. (AlloCure) is a biotechnology company, based in the US. The company develops cell therapies for the treatment of kidney diseases. It develops therapies for kidney injury, kidney transplantation and multi organ failure. The company’s clinical trials include acute kidney injury, epidemiological study of AKI, phase 1 clinical trial in AKI, and phase 2 clinical trial in AKI. Its therapy, AC607 concentrates on acute kidney injury, kidney transplantation, multi organ failure and AKI Diagnostics. AlloCure’s investors include SV Life Sciences, Novo Ventures and Lundbeckfond Ventures. The company was incorporated in 2004. AlloCure is headquartered in Burlington, Massachusetts, the US.

Per Page: 15 25 50

«1...

Construction Reports

Find premium construction research reports. Purchase and download high quality report analysis and much more.

DocStore Search:

DocStore » Research Reports » Construction Reports

Opmedic Group Inc. (OMG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Orbus Pharma Inc. (ORB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Ophthotech Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oncothyreon Inc. (ONTY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

PATH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Amalyte Pharmaceuticals, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Clinquest Group, B.V. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Diffusion Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Alvine Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Promedior, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Trevena, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cyclogenix Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Agios Pharmaceuticals - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Hawthorn Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

AlloCure Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile